You are here: Industry Insights > DNA

News List

Scientists Engineer DNA-based Nanotechnology to Stimulate Potent Antitumor Immune Responses in Preclinical Models The Wistar Institute
September 24, 2020
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma.
Researchers develop highly sensitive blood test for cancer pharmatimes
June 22, 2020
Researchers have developed a new way of analysing cancer patients’ blood for evidence of the disease that could be up to ten times more sensitive than previous methods.
Eurofins Genomics Launches SARS-CoV-2 Plasmid DNA Controls contractpharma
April 17, 2020
Can be used to detect the presence of SARS-CoV-2 virus and are intended for both R&D and diagnostic applications.
New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus worldpharmanews
March 17, 2020
CRISPR-based genetic screens have helped scientists identify genes that are key players in sickle-cell anemia, cancer immunotherapy, lung cancer metastasis, and many other diseases.
“Two-pronged” DNA repair attack could kill drug-resistant cancers pharmatimes
March 16, 2020
A new study has suggested that launching a “two-pronged” attack on cancer’s ability to safeguard its DNA could offer an effective new way of treating the disease.
Supersensitive smart material developed for targeted drug delivery europeanpharmaceuticalreview
March 11, 2020
Scientists have developed a highly sensitive material that can analyse multiple environmental parameters simultaneously, which could be used in drug delivery.
DNA nanostructure stabilisation could enable translation into clinical use europeanpharmaceuticalreview
March 09, 2020
Stabilising DNA nanostructures using glutaraldehyde to tether an electrostatic PEGylated oligolysine net to the DNA enabled them to survive degradation in animal models.
GenScript Partners with Harvard to Develop Ultra-safe Cells Resistant to Natural Viruses contractpharma
September 24, 2019
GenScript, a gene synthesis provider, will provide research support to Harvard University scientist George Church, PhD, for his contributions to the Ultra-safe Cell project ...
AC Immune, UPenn to Research TDP-43 in Neurodegenerative Diseases contractpharma
August 14, 2019
TDP-43, a DNA-binding protein, is a target of growing interest for neuro-orphan indications.
Schreiner MediPharm, Applied DNA Offer Forensic Authentication Feature contractpharma
August 14, 2019
SigNature is based on DNA markers which are deemed to be impossible to counterfeit and recognized as forensic authentication evidence in courts of law.

Previous page 1 2 3 4 5 6 7 8 9 Next page